Affordable cytology Capitalize on RBI's affordable liquid-based cytology technology (ClearPrep) to target resource-limited labs in developing markets across South America, Eastern Europe, and Southeast Asia with cost-effective cancer screening solutions.

Reflex testing edge Leverage the ability to reflex HPV testing from the same collected sample to upsell integrated cervical cancer screening panels, increasing test volume per patient and reducing specimen handling steps for labs.

Global expansion Target small to mid-sized laboratories abroad seeking FDA-registered, high-quality cytology slide preparation to differentiate from conventional methods, aligning with RBI’s global outreach since 2014.

Adjacent oncology use Position ClearPrep for expansion into additional oncology screening workflows such as Fine Needle Aspirates, bladder cancer screening in urine, and oral cancer detection to broaden deployment across departments.

Strategic partnerships Explore collaboration with larger diagnostic players or distributors (similar to the scale of major peers) to accelerate market access, leverage existing sales channels, and scale awareness of affordable cytology solutions.